Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Singulair

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Singulair was produced by Merck & Co..

India denies patent on Pfizer's Xeljanz

India denies patent on Pfizer's Xeljanz

Earlier cases have involved Novartis' cancer drug Glivec (imatinib), Roche 's Pegasys (peginterferon alfa-2a) for hepatitis, Merck &Co's asthma treatment Singulair (montelukast), Gilead's HIV drug Viread (tenofovir) and

Merck & Co's cancer drug Keytruda gaining traction in US

Merck & Co's cancer drug Keytruda gaining traction in US Merck's third-quarter results were hit as expected by the lingering effect of patent expiries on key products such as cancer drug Temodar (temozolomide) and Singulair (montelukast) for asthma, as

Merck cuts MK-3475 deals with Pfizer, Amgen and Incyte

Merck cuts MK-3475 deals with Pfizer, Amgen and Incyte sales of asthma drug Singulair (montelukast) on generic competition, as well as a 14 per cent drop in net income to $781m.

Who tops the pharma list?

Who tops the pharma list? By the end of 2012, Advair (GSK - $8.2bn), Singulair (Merck - $5.5bn) and Diovan (Novartis - $5.7bn) would be among many billion-dollar brands to lose exclusivity during the calendar

GSK loses patent on Tykerb in India

GSK loses patent on Tykerb in India This year has already seen IP setbacks in India for Novartis' leukaemia drug Glivec (imatinib), Merck &Co's Januvia (sitagliptin) diabetes franchise and Singulair (montelukast),   Roche's Pegasys (peginterferon alfa-2a),

1 2 3 4 5 6 7 8 9 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health Insight

Cello Health Insight is the global market research arm of Cello Health. With 35 years’ sector experience, we specialise in...

Latest intelligence

2019: CRISPR and therapeutic gene editing comes of age
Can gene-editing deliver safe and effective therapeutics for patients with intractable diseases?...
The 10-year Web Challenge
Understanding your users’ needs is more critical online today than ever. A site should mould itself around these insights, deliver those needs quickly, efficiently and with plenty of white space....
Downloadable Pack: Understanding Multiple Sclerosis
Inside this downloadable pack, you’ll find a wealth of exclusive information on the way multiple sclerosis is commonly treated today. As well as areas of continuous improvement for the industry....

Infographics